Inogen Appoints Reding to New COO Role

Dow Jones07-02
 

Inogen appointed Andy Reding to a newly created chief operating officer position, effective July 6.

Reding most recently served as chief commercial officer at Viant Medical, and previously served as vice president and general manager of Hillrom Respiratory Health.

He will receive an annual base salary of $500,000, a sign-on cash bonus of $100,000, and an equity award of 130,000 shares which will vest over three years, plus other bonuses and benefits, the medical technology company said.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

July 01, 2026 16:21 ET (20:21 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment